Is proactive health testing just making us more anxious?
Sarah Manavis draws on her pandemic-era health anxiety to question the boom in elective scans and continuous health monitoring. She argues that companies such as Prenuvo, Neko Health, Ezra and Thriva Health market early detection by suggesting that healthy people may harbor hidden dangers, turning vigilance into a profitable source of anxiety. Although some scans uncover serious conditions, she warns that repeated testing can produce only temporary reassurance and make uncertainty increasingly difficult to tolerate.
BerichtsstilInterpretierend
A personal, critical column arguing that proactive testing companies profit from health anxiety and can turn monitoring into a source of illness.

